These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24557073)

  • 1. Biopharmaceutical liquid formulation: a review of the science of protein stability and solubility in aqueous environments.
    Bye JW; Platts L; Falconer RJ
    Biotechnol Lett; 2014 May; 36(5):869-75. PubMed ID: 24557073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility and stability of indomethacin in arginine-assisted solubilization system.
    Qi X; Zhang J; Wang W; Cao D
    Pharm Dev Technol; 2013; 18(4):852-5. PubMed ID: 21749269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications.
    Chiou WL; Kyle LE
    J Pharm Sci; 1979 Oct; 68(10):1224-9. PubMed ID: 512850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-formulation and chemical stability studies of penethamate, a benzylpenicillin ester prodrug, in aqueous vehicles.
    Jain R; Wu Z; Bork O; Tucker IG
    Drug Dev Ind Pharm; 2012 Jan; 38(1):55-63. PubMed ID: 21696334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved stability of trans-resveratrol in aqueous solutions by carboxymethylated (1,3/1,6)-β-D-glucan.
    Francioso A; Mastromarino P; Restignoli R; Boffi A; d'Erme M; Mosca L
    J Agric Food Chem; 2014 Feb; 62(7):1520-5. PubMed ID: 24467639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable, long-term bacterial production of soluble, dimeric, disulfide-bonded protein pharmaceuticals without antibiotic selection.
    Mantile G; Fuchs C; Cordella-Miele E; Peri A; Mukherjee AB; Miele L
    Biotechnol Prog; 2000; 16(1):17-25. PubMed ID: 10662484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of biopharmaceutical parameters in drug development (author's transl)].
    Thoma K
    Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stability of two formulations of recombinant activated factor VIIa reconstituted in inappropriate solvents or at inappropriate volumes.
    Petersson B; Schönwandt AB; Thornstfeldt P; Nedergaard H; Jensen MB; Thornstergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 May; 30(5):917-23. PubMed ID: 18555938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P
    Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
    Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical formulation.
    Lee JC
    Curr Opin Biotechnol; 2000 Feb; 11(1):81-4. PubMed ID: 10679348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a parenteral formulation of trimelamol, a synthetic S-triazine carbinolamine-containing cytotoxic agent.
    Gibson M; Denham AJ; Taylor PM; Payne NI
    J Parenter Sci Technol; 1990; 44(6):306-13. PubMed ID: 2277318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral formulation of a novel antiviral agent, PG301029, in a mixture of gelucire 44/14 and DMA (2:1, wt/wt).
    He Y; Johnson JL; Yalkowsky SH
    AAPS PharmSciTech; 2005 Apr; 6(1):E1-5. PubMed ID: 16353952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational fluid dynamics (CFD) insights into agitation stress methods in biopharmaceutical development.
    Bai G; Bee JS; Biddlecombe JG; Chen Q; Leach WT
    Int J Pharm; 2012 Feb; 423(2):264-80. PubMed ID: 22172288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.